Results 81 to 90 of about 4,992,809 (126)
Blastic plasmacytoid dendritic cell neoplasm is a malignant, aggressive, and rare tumor arising from plasmacytoid dendritic cell precursors. Because of its infrequency, information on clinical features and best treatment options is still lacking ...
Daniel Argüello-Ruiz +2 more
doaj
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare, aggressive neoplasm classified under "acute myeloid leukemia (AML) and related precursor neoplasm" by current WHO classification.
Sumaira Qayoom +3 more
doaj +1 more source
Diagnostic management of blastic plasmacytoid dendritic cell neoplasm (BPDCN) in close interaction with therapeutic considerations. [PDF]
Blastic plasmacytoid dendritic cell neoplasm (BPDCN), a rare malignancy derived from plasmacytoid dendritic cells, can mimic both acute leukemia and aggressive T-cell lymphoma.
Pollak, Matthias +22 more
core +2 more sources
CD4+/CD56+ hematodermic neoplasm (WHO-EORTC) or blastic NK-cell lymphoma (WHO) is a rare aggressive (CD4+)(CD56+)lin- skin-tropic lymphoma of putative early-plasmacytoid dendritic cell origin.
AP Ng +5 more
doaj
Blastic plasmacytoid dendritic cell neoplasm mimicking dermatomyositis
Christopher J. Fay, BA +4 more
doaj +1 more source
Blastic Plasmacytoid Dendritic Cell Neoplasm Expressing the CD13 Myeloid Antigen
Blastic plasmacytoid dendritic cell neoplasm (BPDCN), currently considered to originate from immature plasmacytoid dendritic cells (DC), is a rare and aggressive CD4+CD56+ neoplasm that frequently involves the skin and bone marrow.
Takayuki Takahashi +8 more
core +1 more source
Pseudo-Rosette-Forming Blastic Plasmacytoid Dendritic Cell Neoplasm
Praveen Sharma, Shano Naseem
doaj +1 more source
Blastic plasmacytoid dendritic neoplasm / Nabia Idaam Mustapa Albakari [PDF]
Blastic plasmacytoid dendritic neoplasm (BPCDN) is a rare entity and difficult to diagnose. It is highly aggressive with a poor diagnosis. Early diagnosis may help with treatment.
Mustapa Albakari, Nabia Idaam
core
Background: Myelodysplastic syndromes with chromosome 5 long arm deletion (5q-MDS) may benefit from lenalidomide treatment. However, unresponsive patients have a high risk for clonal evolution and progression to acute myeloid leukemia.
A. Freyrie +13 more
core +1 more source
Blastic plasmacytoid dendritic cell neoplasm: case series and a brief review of literature
Blastic plasmacytoid dendritic cell neoplasm is a very aggressive disease wich has been classified by the World Health Organization among “acute myeloid leukemia and related precursor neoplasms” in 2008.
DI MEO, NICOLA +5 more
core

